The joint annual EFGCP-DIA Conference took place on the 25-26 October 2018 in Brussels. This edition of the conference was especially relevant as it was organised with the aim of taking the stock of the progress achieved in the paediatric field after ten years of Paediatric Regulation and to discuss what could be done to optimise children’s access to new medicines.
Experts touched upon the important aspects of enabling access for different paediatric populations and shared experiences from both regulators and patients’ perspectives.
They also focused on the enhancement of effectiveness in paediatric clinical trials including presentations of a number of projects (conect4children, Think Big) and on the importance of collaboration across stakeholders and best practice sharing. In this regard, two SIOP Europe Board Members participated as speakers.
Prof. Gilles Vassal (Institut Gustave Roussy) illustrated the latest achievements of the ACCELERATE Multistakeholder Paediatric Strategy Forum while Prof. Ruth Ladenstein (St. Anna’s Children’s Hospital) provided the latest updates of the European Reference Network including ERN PaedCan.